vs
Side-by-side financial comparison of Burke & Herbert Financial Services Corp. (BHRB) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
Burke & Herbert Financial Services Corp. is the larger business by last-quarter revenue ($86.5M vs $62.1M, roughly 1.4× Cytek Biosciences, Inc.). Burke & Herbert Financial Services Corp. runs the higher net margin — 34.9% vs -70.9%, a 105.9% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 4.9%). Burke & Herbert Financial Services Corp. produced more free cash flow last quarter ($96.2M vs $-1.8M). Over the past eight quarters, Burke & Herbert Financial Services Corp.'s revenue compounded faster (81.1% CAGR vs 17.7%).
Burke & Herbert Financial Services Corp is a U.S.-based regional financial holding company, offering personal and commercial banking, wealth management, residential mortgage lending, and small business financing services. Its core market covers Virginia and adjacent Mid-Atlantic regions, serving retail consumers, SMEs, and high-net-worth clients.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
BHRB vs CTKB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $86.5M | $62.1M |
| Net Profit | $30.2M | $-44.1M |
| Gross Margin | — | 52.9% |
| Operating Margin | 43.8% | -9.0% |
| Net Margin | 34.9% | -70.9% |
| Revenue YoY | 4.9% | 8.1% |
| Net Profit YoY | 52.8% | -557.1% |
| EPS (diluted) | $1.98 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $86.5M | $62.1M | ||
| Q3 25 | $85.4M | $52.3M | ||
| Q2 25 | $87.1M | $45.6M | ||
| Q1 25 | $83.0M | $41.5M | ||
| Q4 24 | $82.5M | $57.5M | ||
| Q3 24 | $83.8M | $51.5M | ||
| Q2 24 | $69.3M | $46.6M | ||
| Q1 24 | $26.4M | $44.9M |
| Q4 25 | $30.2M | $-44.1M | ||
| Q3 25 | $30.0M | $-5.5M | ||
| Q2 25 | $29.9M | $-5.6M | ||
| Q1 25 | $27.2M | $-11.4M | ||
| Q4 24 | $19.8M | $9.6M | ||
| Q3 24 | $27.6M | $941.0K | ||
| Q2 24 | $-16.9M | $-10.4M | ||
| Q1 24 | $5.2M | $-6.2M |
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 54.6% | ||
| Q1 24 | — | 51.3% |
| Q4 25 | 43.8% | -9.0% | ||
| Q3 25 | 43.3% | -17.6% | ||
| Q2 25 | 42.7% | -23.3% | ||
| Q1 25 | 39.6% | -36.1% | ||
| Q4 24 | 24.6% | 5.2% | ||
| Q3 24 | 39.2% | -8.2% | ||
| Q2 24 | -27.5% | -18.3% | ||
| Q1 24 | 22.3% | -23.9% |
| Q4 25 | 34.9% | -70.9% | ||
| Q3 25 | 35.1% | -10.5% | ||
| Q2 25 | 34.3% | -12.2% | ||
| Q1 25 | 32.8% | -27.5% | ||
| Q4 24 | 24.0% | 16.8% | ||
| Q3 24 | 33.0% | 1.8% | ||
| Q2 24 | -24.4% | -22.4% | ||
| Q1 24 | 19.8% | -13.8% |
| Q4 25 | $1.98 | — | ||
| Q3 25 | $1.97 | — | ||
| Q2 25 | $1.97 | — | ||
| Q1 25 | $1.80 | — | ||
| Q4 24 | $1.72 | — | ||
| Q3 24 | $1.82 | — | ||
| Q2 24 | $-1.41 | — | ||
| Q1 24 | $0.69 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $90.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $854.6M | $341.7M |
| Total Assets | $7.9B | $461.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $90.9M | ||
| Q3 25 | — | $93.3M | ||
| Q2 25 | — | $75.5M | ||
| Q1 25 | — | $95.3M | ||
| Q4 24 | — | $98.7M | ||
| Q3 24 | — | $162.3M | ||
| Q2 24 | — | $177.9M | ||
| Q1 24 | — | $168.8M |
| Q4 25 | $854.6M | $341.7M | ||
| Q3 25 | $822.2M | $378.6M | ||
| Q2 25 | $780.0M | $377.6M | ||
| Q1 25 | $758.0M | $379.6M | ||
| Q4 24 | $730.2M | $395.7M | ||
| Q3 24 | $738.1M | $385.5M | ||
| Q2 24 | $693.1M | $389.1M | ||
| Q1 24 | $319.3M | $392.6M |
| Q4 25 | $7.9B | $461.5M | ||
| Q3 25 | $7.9B | $494.9M | ||
| Q2 25 | $8.1B | $493.3M | ||
| Q1 25 | $7.8B | $482.6M | ||
| Q4 24 | $7.8B | $499.5M | ||
| Q3 24 | $7.9B | $491.2M | ||
| Q2 24 | $7.8B | $483.7M | ||
| Q1 24 | $3.7B | $492.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $107.9M | $-771.0K |
| Free Cash FlowOCF − Capex | $96.2M | $-1.8M |
| FCF MarginFCF / Revenue | 111.2% | -2.9% |
| Capex IntensityCapex / Revenue | 13.5% | 1.6% |
| Cash ConversionOCF / Net Profit | 3.57× | — |
| TTM Free Cash FlowTrailing 4 quarters | $164.1M | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $107.9M | $-771.0K | ||
| Q3 25 | $39.3M | $-3.9M | ||
| Q2 25 | $41.0K | $108.0K | ||
| Q1 25 | $37.6M | $-125.0K | ||
| Q4 24 | $85.8M | $2.0M | ||
| Q3 24 | $47.8M | $13.2M | ||
| Q2 24 | $-46.0M | $6.2M | ||
| Q1 24 | $7.1M | $4.0M |
| Q4 25 | $96.2M | $-1.8M | ||
| Q3 25 | $35.4M | $-4.6M | ||
| Q2 25 | $-3.4M | $-1.5M | ||
| Q1 25 | $35.9M | $-974.0K | ||
| Q4 24 | $81.2M | $1.1M | ||
| Q3 24 | $46.0M | $12.2M | ||
| Q2 24 | $-47.0M | $5.2M | ||
| Q1 24 | $5.6M | $3.4M |
| Q4 25 | 111.2% | -2.9% | ||
| Q3 25 | 41.5% | -8.7% | ||
| Q2 25 | -3.9% | -3.2% | ||
| Q1 25 | 43.2% | -2.3% | ||
| Q4 24 | 98.5% | 1.9% | ||
| Q3 24 | 55.0% | 23.7% | ||
| Q2 24 | -67.8% | 11.0% | ||
| Q1 24 | 21.2% | 7.6% |
| Q4 25 | 13.5% | 1.6% | ||
| Q3 25 | 4.5% | 1.3% | ||
| Q2 25 | 3.9% | 3.5% | ||
| Q1 25 | 2.1% | 2.0% | ||
| Q4 24 | 5.5% | 1.6% | ||
| Q3 24 | 2.1% | 2.0% | ||
| Q2 24 | 1.5% | 2.3% | ||
| Q1 24 | 5.7% | 1.3% |
| Q4 25 | 3.57× | — | ||
| Q3 25 | 1.31× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 1.38× | — | ||
| Q4 24 | 4.33× | 0.21× | ||
| Q3 24 | 1.73× | 14.05× | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.36× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BHRB
Segment breakdown not available.
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
